Research & Development
Macrogen receives Korean Ministry of Food and Drug Safety export approval for 'AxenTM COVID-19 RT'
21 May 2020 -

Macrogen (KOSDAQ: 038290), a Korea-based biotech company, has received export approval from the nation's Ministry of Food and Drug Safety for the company's COVID-19 test kit 'AxenTM COVID-19 RT', it was reported on Wednesday.

The test kit uses RT-PCR, and can confirm if a person is infected with COVID-19 in two hours, which enables a large number of tests to be completed quickly and efficiently. The kit detects ORF1ab and E genes, two genes related to COVID-19.

Presently, the company is preparing to receive Emergency Use Authorization from the United States FDA and Europe's CE In-Vitro Diagnostics. These authorisations are expected to increase Macrogen's exports across the US and Europe, as well as Brazil and Uruguay, where the test kit is currently under negotiation.

Login
Username:

Password: